oral formulation
Showing 26 - 50 of >10,000
Healthy Participants Trial in Neuss (Semaglutide)
Not yet recruiting
- Healthy Participants
-
Neuss, GermanyNovo Nordisk Investigational Site
Aug 10, 2023
Premature Birth of Newborn Trial in Netanya (Oral Formulation of Insulin, Placebo)
Terminated
- Premature Birth of Newborn
- Oral Formulation of Insulin
- Placebo
-
Netanya, IsraelNICU, Laniado Hospital
Mar 16, 2021
Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)
Not yet recruiting
- Healthy
- BI 1810631 (C-14) formulation 1
- +2 more
- (no location specified)
May 25, 2023
Healthy Trial in San Antonio (Decitabine, Tetrahydrouridine)
Recruiting
- Healthy
-
San Antonio, TexasWorldwide Clinical Trails Early Phase Services
Apr 14, 2023
Healthy Trial ([¹4C] BI 685509 formulation 1, [¹4C] BI 685509 formulation 2, BI 685509 formulation 3)
Not yet recruiting
- Healthy
- [¹⁴C] BI 685509 formulation 1
- +2 more
- (no location specified)
Aug 23, 2022
Insomnia Trial in San Francisco (Defined CBD, Placebo)
Active, not recruiting
- Insomnia
- Defined CBD
- Placebo
-
San Francisco, CaliforniaDefined Research
Jul 26, 2022
Primary Liver Cancer Trial in Marseille (GNS561 oral tablets and capsules)
Not yet recruiting
- Primary Liver Cancer
- GNS561 oral tablets and capsules
-
Marseille, FranceGenoscience Pharma
Apr 25, 2022
Hair Loss, Hair Thinning Trial (Herbal Supplementation)
Withdrawn
- Hair Loss
- Hair Thinning
- Herbal Supplementation
- (no location specified)
Oct 19, 2021
Solid Tumors Trial in Budapest ([¹4C]-BI 907828 mixed with BI 907828 (formulation 1), [¹4C]-BI 907828 mixed with BI 907828
Recruiting
- Solid Tumors
- [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)
- +2 more
-
Budapest, HungaryPRA Hungary Ltd.
Jan 9, 2023
Gastroenteritis Trial in China (GSK's liquid oral live attenuated HRV, PCV-free liquid formulation of GSK's oral live attenuated
Recruiting
- Gastroenteritis
- GSK's liquid oral live attenuated HRV
- PCV-free liquid formulation of GSK's oral live attenuated HRV
-
Chengdu, Sichuan, China
- +7 more
Sep 7, 2023
Solid Tumor, Adult Trial in Amsterdam (ModraDoc006/r)
Withdrawn
- Solid Tumor, Adult
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek
Feb 7, 2022
Gingivitis Trial in Ljubljana (Neutral electrolyzed water, Placebo, Chlorhexidine digluconate)
Active, not recruiting
- Gingivitis
- Neutral electrolyzed water
- +2 more
-
Ljubljana, SloveniaUniversity of Ljubljana
Jan 23, 2023
Healthy Trial in Merksem (FDC of macitentan/tadalafil (10 mg/20 mg), Macitentan 10 mg, Tadalafil 20 mg)
Completed
- Healthy
- FDC of macitentan/tadalafil (10 mg/20 mg)
- +2 more
-
Merksem, BelgiumClinical Pharmacology Unit
Sep 13, 2022
Pain Trial in Jerusalem (CBD-sesame oil capsule, CBD-LNL capsule, CBD powder form capsule)
Completed
- Pain
- CBD-sesame oil capsule
- +2 more
-
Jerusalem, IsraelHadassah Medical Organization
Mar 20, 2022
Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)
Completed
- Healthy
- R1: Reference Product X
- +12 more
-
Nottingham, United KingdomQuotient Sciences
Dec 7, 2022
Healthy Volunteers Trial in Miami (BIIB104 Reference Formulation, BIIB104 Test Formulation)
Completed
- Healthy Volunteers
- BIIB104 Reference Formulation
- BIIB104 Test Formulation
-
Miami, FloridaQPS MRA
Feb 21, 2022
Healthy Volunteers, Type 2 Diabetes Trial in Berlin (Oral semaglutide)
Completed
- Healthy Volunteers
- Type 2 Diabetes
- Oral semaglutide
-
Berlin, GermanyNovo Nordisk Investigational Site
Sep 27, 2021
Healthy Volunteers Trial in Brooklyn (AZD5055 solution for infusion, AZD5055 oral suspension, AZD5055 film-coated tablet)
Recruiting
- Healthy Volunteers
- AZD5055 solution for infusion
- +3 more
-
Brooklyn, MarylandResearch Site
Dec 15, 2022
Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])
Completed
- Biological Availability
- Dasatinib ASD 100 mg
- Dasatinib 140 MG [Sprycel]
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Jun 28, 2022